Report Detail
Global (United States, European Union and China) Multivalent Vaccines Market Research Report 2019-2025
- RnM3363832 |
- 01 July, 2020 |
- Global |
- 153 Pages |
- QYResearch |
- Pharma & Healthcare
Multivalent Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multivalent Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Multivalent Vaccines market is segmented into
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Segment by Application, the Multivalent Vaccines market is segmented into
Pediatrics
Adults
Regional and Country-level Analysis
The Multivalent Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Multivalent Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Multivalent Vaccines Market Share Analysis
Multivalent Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Multivalent Vaccines business, the date to enter into the Multivalent Vaccines market, Multivalent Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline, plc (U.K.)
Pfizer, Inc. (U.S.)
Merck & Co., Inc. (U.S.)
Sanofi Pasteur SA (France)
Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions, Inc. (U.S.)
Johnson & Johnson (U.S.)
MedImmune, LLC (U.S.)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo (Japan)
Protein Sciences Corporation (U.S.)
Panacea Biotec (India)
1 Study Coverage
- 1.1 Multivalent Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key Multivalent Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Multivalent Vaccines Market Size Growth Rate by Type
- 1.4.2 Conjugate Vaccines
- 1.4.3 Inactivated and Subunit Vaccines
- 1.4.4 Live Attenuated Vaccines
- 1.4.5 Toxoid Vaccines
- 1.4.6 Recombinant Vaccines
- 1.5 Market by Application
- 1.5.1 Global Multivalent Vaccines Market Size Growth Rate by Application
- 1.5.2 Pediatrics
- 1.5.3 Adults
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Multivalent Vaccines Market Size, Estimates and Forecasts
- 2.1.1 Global Multivalent Vaccines Revenue 2015-2026
- 2.1.2 Global Multivalent Vaccines Sales 2015-2026
- 2.2 Global Multivalent Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Multivalent Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Multivalent Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Multivalent Vaccines Competitor Landscape by Players
- 3.1 Multivalent Vaccines Sales by Manufacturers
- 3.1.1 Multivalent Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 Multivalent Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 Multivalent Vaccines Revenue by Manufacturers
- 3.2.1 Multivalent Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 Multivalent Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Multivalent Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Multivalent Vaccines Revenue in 2019
- 3.2.5 Global Multivalent Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Multivalent Vaccines Price by Manufacturers
- 3.4 Multivalent Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Multivalent Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Multivalent Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Multivalent Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Multivalent Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global Multivalent Vaccines Sales by Type (2015-2020)
- 4.1.2 Global Multivalent Vaccines Revenue by Type (2015-2020)
- 4.1.3 Multivalent Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Multivalent Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Multivalent Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global Multivalent Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 Multivalent Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Multivalent Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Multivalent Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global Multivalent Vaccines Sales by Application (2015-2020)
- 5.1.2 Global Multivalent Vaccines Revenue by Application (2015-2020)
- 5.1.3 Multivalent Vaccines Price by Application (2015-2020)
- 5.2 Multivalent Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Multivalent Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global Multivalent Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Multivalent Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Multivalent Vaccines by Country
- 6.1.1 North America Multivalent Vaccines Sales by Country
- 6.1.2 North America Multivalent Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Multivalent Vaccines Market Facts & Figures by Type
- 6.3 North America Multivalent Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe Multivalent Vaccines by Country
- 7.1.1 Europe Multivalent Vaccines Sales by Country
- 7.1.2 Europe Multivalent Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Multivalent Vaccines Market Facts & Figures by Type
- 7.3 Europe Multivalent Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Multivalent Vaccines by Region
- 8.1.1 Asia Pacific Multivalent Vaccines Sales by Region
- 8.1.2 Asia Pacific Multivalent Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Multivalent Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific Multivalent Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Multivalent Vaccines by Country
- 9.1.1 Latin America Multivalent Vaccines Sales by Country
- 9.1.2 Latin America Multivalent Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Multivalent Vaccines Market Facts & Figures by Type
- 9.3 Central & South America Multivalent Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Multivalent Vaccines by Country
- 10.1.1 Middle East and Africa Multivalent Vaccines Sales by Country
- 10.1.2 Middle East and Africa Multivalent Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Multivalent Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa Multivalent Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 GlaxoSmithKline, plc (U.K.)
- 11.1.1 GlaxoSmithKline, plc (U.K.) Corporation Information
- 11.1.2 GlaxoSmithKline, plc (U.K.) Description and Business Overview
- 11.1.3 GlaxoSmithKline, plc (U.K.) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Products Offered
- 11.1.5 GlaxoSmithKline, plc (U.K.) Related Developments
- 11.2 Pfizer, Inc. (U.S.)
- 11.2.1 Pfizer, Inc. (U.S.) Corporation Information
- 11.2.2 Pfizer, Inc. (U.S.) Description and Business Overview
- 11.2.3 Pfizer, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pfizer, Inc. (U.S.) Multivalent Vaccines Products Offered
- 11.2.5 Pfizer, Inc. (U.S.) Related Developments
- 11.3 Merck & Co., Inc. (U.S.)
- 11.3.1 Merck & Co., Inc. (U.S.) Corporation Information
- 11.3.2 Merck & Co., Inc. (U.S.) Description and Business Overview
- 11.3.3 Merck & Co., Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Merck & Co., Inc. (U.S.) Multivalent Vaccines Products Offered
- 11.3.5 Merck & Co., Inc. (U.S.) Related Developments
- 11.4 Sanofi Pasteur SA (France)
- 11.4.1 Sanofi Pasteur SA (France) Corporation Information
- 11.4.2 Sanofi Pasteur SA (France) Description and Business Overview
- 11.4.3 Sanofi Pasteur SA (France) Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Pasteur SA (France) Multivalent Vaccines Products Offered
- 11.4.5 Sanofi Pasteur SA (France) Related Developments
- 11.5 Astellas Pharma Inc. (Japan)
- 11.5.1 Astellas Pharma Inc. (Japan) Corporation Information
- 11.5.2 Astellas Pharma Inc. (Japan) Description and Business Overview
- 11.5.3 Astellas Pharma Inc. (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Astellas Pharma Inc. (Japan) Multivalent Vaccines Products Offered
- 11.5.5 Astellas Pharma Inc. (Japan) Related Developments
- 11.6 CSL Limited (Australia)
- 11.6.1 CSL Limited (Australia) Corporation Information
- 11.6.2 CSL Limited (Australia) Description and Business Overview
- 11.6.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 CSL Limited (Australia) Multivalent Vaccines Products Offered
- 11.6.5 CSL Limited (Australia) Related Developments
- 11.7 Emergent BioSolutions, Inc. (U.S.)
- 11.7.1 Emergent BioSolutions, Inc. (U.S.) Corporation Information
- 11.7.2 Emergent BioSolutions, Inc. (U.S.) Description and Business Overview
- 11.7.3 Emergent BioSolutions, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Products Offered
- 11.7.5 Emergent BioSolutions, Inc. (U.S.) Related Developments
- 11.8 Johnson & Johnson (U.S.)
- 11.8.1 Johnson & Johnson (U.S.) Corporation Information
- 11.8.2 Johnson & Johnson (U.S.) Description and Business Overview
- 11.8.3 Johnson & Johnson (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Johnson & Johnson (U.S.) Multivalent Vaccines Products Offered
- 11.8.5 Johnson & Johnson (U.S.) Related Developments
- 11.9 MedImmune, LLC (U.S.)
- 11.9.1 MedImmune, LLC (U.S.) Corporation Information
- 11.9.2 MedImmune, LLC (U.S.) Description and Business Overview
- 11.9.3 MedImmune, LLC (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 MedImmune, LLC (U.S.) Multivalent Vaccines Products Offered
- 11.9.5 MedImmune, LLC (U.S.) Related Developments
- 11.10 Serum Institute of India Pvt. Ltd. (India)
- 11.10.1 Serum Institute of India Pvt. Ltd. (India) Corporation Information
- 11.10.2 Serum Institute of India Pvt. Ltd. (India) Description and Business Overview
- 11.10.3 Serum Institute of India Pvt. Ltd. (India) Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Products Offered
- 11.10.5 Serum Institute of India Pvt. Ltd. (India) Related Developments
- 11.1 GlaxoSmithKline, plc (U.K.)
- 11.1.1 GlaxoSmithKline, plc (U.K.) Corporation Information
- 11.1.2 GlaxoSmithKline, plc (U.K.) Description and Business Overview
- 11.1.3 GlaxoSmithKline, plc (U.K.) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Products Offered
- 11.1.5 GlaxoSmithKline, plc (U.K.) Related Developments
- 11.12 Mitsubishi Tanabe Pharma Corporation (Japan)
- 11.12.1 Mitsubishi Tanabe Pharma Corporation (Japan) Corporation Information
- 11.12.2 Mitsubishi Tanabe Pharma Corporation (Japan) Description and Business Overview
- 11.12.3 Mitsubishi Tanabe Pharma Corporation (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Mitsubishi Tanabe Pharma Corporation (Japan) Products Offered
- 11.12.5 Mitsubishi Tanabe Pharma Corporation (Japan) Related Developments
- 11.13 Daiichi Sankyo (Japan)
- 11.13.1 Daiichi Sankyo (Japan) Corporation Information
- 11.13.2 Daiichi Sankyo (Japan) Description and Business Overview
- 11.13.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Daiichi Sankyo (Japan) Products Offered
- 11.13.5 Daiichi Sankyo (Japan) Related Developments
- 11.14 Protein Sciences Corporation (U.S.)
- 11.14.1 Protein Sciences Corporation (U.S.) Corporation Information
- 11.14.2 Protein Sciences Corporation (U.S.) Description and Business Overview
- 11.14.3 Protein Sciences Corporation (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Protein Sciences Corporation (U.S.) Products Offered
- 11.14.5 Protein Sciences Corporation (U.S.) Related Developments
- 11.15 Panacea Biotec (India)
- 11.15.1 Panacea Biotec (India) Corporation Information
- 11.15.2 Panacea Biotec (India) Description and Business Overview
- 11.15.3 Panacea Biotec (India) Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Panacea Biotec (India) Products Offered
- 11.15.5 Panacea Biotec (India) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Multivalent Vaccines Market Estimates and Projections by Region
- 12.1.1 Global Multivalent Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global Multivalent Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America Multivalent Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: Multivalent Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: Multivalent Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: Multivalent Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe Multivalent Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: Multivalent Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: Multivalent Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: Multivalent Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Multivalent Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Multivalent Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Multivalent Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Multivalent Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Multivalent Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Multivalent Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: Multivalent Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Multivalent Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Multivalent Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Multivalent Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Multivalent Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Multivalent Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Multivalent Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Multivalent Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Multivalent Vaccines. Industry analysis & Market Report on Multivalent Vaccines is a syndicated market report, published as Global (United States, European Union and China) Multivalent Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Multivalent Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
